test

Brendan Corcoran

@Valence8 Us Lp

Latest period2024 - Q3ReportedManaged Assets$241.102MTotal holdings56
Assets growth rate25.66%Assets growth rate (2-Q avg)12.87%Continuous growth in asset value5 quarters

Portfolio positions

This chart displays the top 10 holdings in Valence8 Us Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 56 positions.

Assets under management

The assets under management (AUM) of Valence8 Us Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 241.102M in assets, with a quarterly growth rate of 25.66% and a 2-quarter average growth rate of 12.87%. The portfolio is managed by Brendan Corcoran, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AZNAstrazeneca Plc
Recent Activity
New Position
2.07%
$4.986M↑ Call
64,000 shares@ $77.91 avg price
AMGNAmgen Inc
Recent Activity
New Position
0.54%
$1.289M↓ Put
4,000 shares@ $322.21 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
New Position
0.47%
$1.121M
22,206 shares@ $50.5 avg price
INSMInsmed Inc
Recent Activity
New Position
0.44%
$1.056M↑ Call
14,465 shares@ $73.0 avg price
JAZZJazz Pharmaceuticals Plc
Recent Activity
New Position
0.42%
$999,236
8,969 shares@ $111.41 avg price
BMYBristol-myers Squibb Co
Recent Activity
New Position
0.39%
$920,196
17,785 shares@ $51.75 avg price
ASNDAscendis Pharma A S
Recent Activity
New Position
0.29%
$684,586
4,585 shares@ $149.31 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
New Position
0.26%
$618,883↑ Call
11,141 shares@ $55.56 avg price
CRSPCrispr Therapeutics Ag
Recent Activity
New Position
0.26%
$615,438↑ Call
13,100 shares@ $46.98 avg price
INDVIndivior Plc
Recent Activity
New Position
0.24%
$564,186
57,293 shares@ $9.85 avg price